Acute Ischemic Stroke Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight

DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Acute Ischemic Stroke Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Acute Ischemic Stroke market report covers emerging drugs, treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Acute Ischemic Stroke: An Overview
Acute Ischemic Stroke (AIS) occurs when blood flow through a brain artery is blocked by a clot- a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, the more common of the two, occurs when a clot forms within an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from elsewhere in the body, such as the heart, and travels through the bloodstream only to become stuck in a narrower vessel in the brain.

Treatment of acute ischemic stroke (AIS) consists of a multidisciplinary approach that, more than ever, requires the involvement of the critical care specialist. Antiplatelet therapy is an important cornerstone of treatment for preventing stroke and transient ischemic attacks (TIAs).

Acute Ischemic Stroke Market Key Facts
• According to the World Health Organization (WHO), an estimated 15 million individuals worldwide suffer from stroke yearly. Of these, 5 million die, and another 5 million are left permanently disabled.
• As per the study conducted by Edward C Jauch et al. 2019, nearly 800,000 people suffer from strokes each year in the United States, and 82-92% of these strokes are ischemic. Stroke is the fifth leading cause of adult death and disability
• As per the Stroke Association of UK 2018, Up to 25% of childhood Ischemic strokes are linked to congenital heart disease.
• As per DelveInsight, the Acute Ischemic Stroke (AIS) Market size is anticipated to grow during the forecast period owing to the launch of upcoming therapies and an increased patient pool. Factors such as improving healthcare infrastructure in emerging economies increased investment by pharmaceutical companies for research and development of improved drugs, and the rising number of pain management centers will further fuel the market in a positive direction.

Acute Ischemic Stroke Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Acute Ischemic Stroke market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Acute Ischemic Stroke market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How Acute Ischemic Stroke Market will Grow by 2032:
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Ischemic Stroke Epidemiology
The epidemiology section covers detailed insights into the historical and current Acute Ischemic Stroke patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Acute Ischemic Stroke Epidemiology Segmentation
• Total Prevalent Cases
• Diagnosed and Treatable Cases
• Age-specific Prevalent Cases
• Gender-specific Prevalent Cases

Get Key Insights Into the Evolving Acute Ischemic Stroke Epidemiology Trends:
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Ischemic Stroke Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute Ischemic Stroke market or expected to get launched in the market during the study period. The analysis covers Acute Ischemic Stroke market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Acute Ischemic Stroke Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Ischemic Stroke Therapeutics Assessment
The dynamics of the Acute Ischemic Stroke market are anticipated to change in the coming years, owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of emerging therapies during the forecast period. Globally, several key companies are working towards the development of new treatment therapies for Acute Ischemic Stroke. The launch of emerging therapies is expected to transform the treatment scenario in the coming years.

Some of the Key Companies in the Acute ischemic stroke market include:
• Athersys
• Abbvie
• Bristol-Myers Squibb
• Lumosa Therapeutics
• Teijin Pharma Limited
And many others.

Acute Ischemic Stroke Therapies covered in the report include:
• MultiStem
• BMS-986177
• LT-3001
• Elezanumab
And many more

Learn More About the Emerging Therapies & Key Companies in the Acute Ischemic Stroke Therapeutics Market:
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Acute Ischemic Stroke Competitive Intelligence Analysis
4. Acute Ischemic Stroke Market Overview at a Glance
5. Acute Ischemic Stroke Disease Background and Overview
6. Acute Ischemic Stroke Patient Journey
7. Acute Ischemic Stroke Epidemiology and Patient Population
8. Acute Ischemic Stroke Treatment Algorithm, Current Treatment, and Medical Practices
9. Acute Ischemic Stroke Unmet Needs
10. Key Endpoints of Acute Ischemic Stroke Treatment
11. Acute Ischemic Stroke Marketed Products
12. Acute Ischemic Stroke Emerging Therapies
13. Acute Ischemic Stroke Seven Major Market Analysis
14. Attribute Analysis
15. Acute Ischemic Stroke Market Outlook (7 major markets)
16. Acute Ischemic Stroke Access and Reimbursement Overview
17. KOL Views on the Acute Ischemic Stroke Market.
18. Acute Ischemic Stroke Market Drivers
19. Acute Ischemic Stroke Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.